Biogen hires Viehbacher as CEO

Ttomorrow to you, and that’s good. Crystal clear blue skies and a cool breeze envelope the leafy Pharmalot campus, where the official mascot is anticipating game day and – most importantly – the coffee kettle is heating up. After all, starting the day without a cup of stimulation is simply not done. So our pick today is always seasonal pumpkin spice. Meanwhile, we’ve once again put together another laundry list of interesting things to do as you begin your own journey today. We hope everything goes well and that you conquer the world. On that note, time to crack. Good luck. …

Biogen named Christopher Viehbacher, who previously headed Sanofi, as its new CEO, opening a new chapter for one of the first and most successful biotech companies but one that has struggled since the disastrous launch of Alzheimer’s drug Aduhelm., writes STAT. Viehbacher, 62, will take the reins on Monday, succeeding Michel Vounatsos, who announced his impending resignation in May. At Sanofi, Viehbacher was largely responsible for restructuring the drugmaker and deepening the partnership with Regeneron Pharmaceuticals. But he was ousted in 2014 after an embarrassing public clash with Sanofi’s board.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days for free!

BEGIN

Leave a Comment

Your email address will not be published. Required fields are marked *